Regulation of cyclooxygenase-2 expression by the translational silencer TIA-1

被引:163
作者
Dixon, DA
Balch, GC
Kedersha, N
Anderson, P
Zimmerman, GA
Beauchamp, RD
Prescott, SM
机构
[1] Vanderbilt Univ, Med Ctr, Surg Oncol Res Lab, Dept Surg, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Med Ctr, Surg Oncol Res Lab, Dept Canc Biol, Nashville, TN 37232 USA
[3] Univ Utah, Eccles Program Human Mol Biol & Genet, Salt Lake City, UT 84112 USA
[4] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA
[5] Brigham & Womens Hosp, Div Rheumatol & Immunol, Boston, MA 02115 USA
关键词
COX-2; cyclooxygenase-2; prostaglandins; TIA-1; AU-rich element;
D O I
10.1084/jem.20030616
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The cyclooxygenase-2 (COX-2) enzyme catalyzes the rate-limiting step of prostaglandin formation in inflammatory states, and COX-2 overexpression plays a key role in carcinogenesis. To understand the mechanisms regulating COX-2 expression, we examined its posttranscriptional regulation mediated through the AU-rich element (ARE) within the COX-2 mRNA 3'-untranslated region (3'UTR). RNA binding studies, performed to identify ARE-binding regulatory factors, demonstrated binding of the translational repressor protein TIA-1 to COX-2 mRNA. The significance of TIA-1-mediated regulation of COX-2 expression was observed in TIA-1 null fibroblasts that produced significantly more COX-2 protein than wild-type fibroblasts. However, TIA-1 deficiency did not alter COX-2 transcription or mRNA turnover. Colon cancer cells demonstrated to overexpress COX-2 through increased polysome association with COX-2 mRNA also showed defective TIA-1 binding both in vitro and in vivo. These findings implicate that TIA-1 functions as a translational silencer of COX-2 expression and support the hypothesis that dysregulated RNA-binding of TIA-1 promotes COX-2 expression in neoplasia.
引用
收藏
页码:475 / 481
页数:7
相关论文
共 21 条
  • [1] Anderson P, 2002, J CELL SCI, V115, P3227
  • [2] Misregulated posttranscriptional checkpoints: Inflammation and tumorigenesis
    Brewer, G
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (02) : F1 - F4
  • [3] CHEN CYA, 1995, MOL CELL BIOL, V15, P5777
  • [4] Post-transcriptional control of cyclooxygenase-2 gene expression -: The role of the 3′-untranslated region
    Dixon, DA
    Kaplan, CD
    McIntyre, TM
    Zimmerman, GA
    Prescott, SM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (16) : 11750 - 11757
  • [5] Dixon DA, 2003, PROG EXP TUMOR RES, V37, P52
  • [6] Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells
    Dixon, DA
    Tolley, ND
    King, PH
    Nabors, LB
    McIntyre, TM
    Zimmerman, GA
    Prescott, SM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (11) : 1657 - 1665
  • [7] The apoptosis-promoting factor TIA-1 is a regulator of alternative pre-mRNA splicing
    Förch, P
    Puig, O
    Kedersha, N
    Martínez, C
    Granneman, S
    Séraphin, B
    Anderson, P
    Valcárcel, J
    [J]. MOLECULAR CELL, 2000, 6 (05) : 1089 - 1098
  • [8] Gouble A, 2002, CANCER RES, V62, P1489
  • [9] Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2
    Gupta, RA
    DuBois, RN
    [J]. NATURE REVIEWS CANCER, 2001, 1 (01) : 11 - 21
  • [10] KAWAKAMI A, 1994, J IMMUNOL, V152, P4937